Joel Krikston is a Managing Director with Merck’s Global Health Innovation Fund, LLC (“GHI”). Joel is focused on identifying new investment opportunities in Health Information Technology and Technology Enabled Solutions with an emphasis on Clinical Awareness, Accountable Care Solutions and Population Health. Joel currently serves on the Boards of Arcadia Healthcare Solutions, CareSync, MedCPU, Aventura, and PatientSafe Solutions and is a Board Observer at Electrocore, LLC. Joel also serves as GHI’s representative to the New York Digital Health Accelerator, Health Tech Capital and ICEX.

Mr. Krikston has over 20 years of experience in healthcare innovation. Prior to joining Merck GHI in 2013, he was an Investment Principal at Johnson & Johnson Development Corporation, leading the group’s efforts in healthcare technology and diagnostics while also supporting medical devices and pharmaceuticals. He has previously served on the Boards of GetWell Network (acquired by Welsh Carson in 2012) and Imacor. During Mr. Krikston’s seven years with J&J, he served in a range of business development roles at both the corporate and operating company level focused on the identification, formation, development and launch of new businesses in emergent healthcare segments.

Prior to joining Johnson & Johnson, Joel spent over eight years as an investment banker, covering an array of healthcare clients and included experience at BNP Paribas, JPMorgan and ABN Amro.  Joel has an MBA with honors from the Stern School of Business at NYU and completed his Bachelor’s degree in Finance and International Business at Fairfield University.